RT Journal Article
SR Electronic
T1 Unique prediction of developmental psychopathology from genetic and familial risk
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.08.20186908
DO 10.1101/2020.09.08.20186908
A1 Loughnan, Robert
A1 Palmer, Clare E.
A1 Makowski, Carolina
A1 Thompson, Wesley K.
A1 Barch, Deanna M.
A1 Jernigan, Terry L.
A1 Dale, Anders M.
A1 Fan, Chun Chieh
YR 2021
UL http://medrxiv.org/content/early/2021/07/27/2020.09.08.20186908.abstract
AB Background Early detection is critical for easing the rising burden of psychiatric disorders. However, the specificity of psychopathological measurements and genetic predictors is unclear among youth.Methods We measured associations between genetic risk for psychopathology (polygenic risk scores (PRS) and family history (FH) measures) and a wide range of behavioral measures in a large sample (n=5204) of early adolescent participants (9-11 years) from the Adolescent Brain and Cognitive Development (ABCD) StudySM. Associations were measured both with and without taking into consideration shared variance across measures of genetic risk.Results Polygenic risk for Attention Deficit Hyperactivity Disorder (ADHD) and depression (DEP) shared many significant associations with externalizing, internalizing and psychosis-related behaviors. However, when accounting for all measures of genetic and familial risk these two PRS also showed clear, unique patterns of association: the DEP PRS showed significantly stronger associations with somatic complaints and depression symptoms; whereas the ADHD PRS showed stronger associations with ADHD symptoms, impulsivity and prodromal psychosis. The Schizophrenia PRS showed a unique negative association with performance on cognitive tasks measuring fluid abilities, such as working memory and executive function, that was not accounted for by other measures of genetic risk. FH accounted for unique variability in behavior above and beyond PRS and vice versa with FH measures explaining a greater proportion of unique variability compared to the PRS.Conclusion Our results indicate that, among youth, many behaviors show shared genetic influences; however, there is also specificity in the profile of emerging psychopathologies for individuals with high genetic risk for particular disorders. This may be useful for quantifying early, differential risk for psychopathology in development.Funding The ABCD Study is supported by the National Institutes of Health and additional federal partners under award numbers U01DA041022, U01DA041028, U01DA041048, U01DA041089, U01DA041106, U01DA041117, U01DA041120, U01DA041134, U01DA041148, U01DA041156, U01DA041174, U24DA041123, U24DA041147, U01DA041093, and U01DA041025. A full list of supporters is available at https://abcdstudy.org/federal-partners.html. R.L was supported by Kavli Innovative Research Grant under award number 2019-1624. C.F. was supported by grant R01MH122688 and RF1MH120025 funded by the National Institute for Mental Health (NIMH).Competing Interest StatementDr. Dale reports that he was a Founder of and holds equity in CorTechs Labs, Inc., and serves on its Scientific Advisory Board. He is a member of the Scientific Advisory Board of Human Longevity, Inc. He receives funding through research grants from GE Healthcare to UCSD. The terms of these arrangements have been reviewed by and approved by UCSD in accordance with its conflict of interest policies. Dr. Dale also reports that he has memberships with the following research consortia: Alzheimers Disease Genetics Consortium (ADGC); Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA); Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL); Psychiatric Genomics Consortium (PGC).Funding StatementData used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development (ABCD) Study (https://abcdstudy.org), held in the NIMH Data Archive (NDA). The ABCD Study is supported by the National Institutes of Health and additional federal partners under award numbers U01DA041022, U01DA041028, U01DA041048, U01DA041089, U01DA041106, U01DA041117, U01DA041120, U01DA041134, U01DA041148, U01DA041156, U01DA041174, U24DA041123, U24DA041147, U01DA041093, and U01DA041025. R.L. was supported by the Kavli Innovative Research Grant (2019-1624) and C.F. was supported by a NIMH award (R01MH122688).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UCSD IRB approved all data collection protocols for ABCD. IRB number: 160091. All analyses in this study used deidentified data, therefore no additional IRB approval was required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available to download from the NIMH Data Archive ABCD Collection Release 2.0.1 (DOI: 10.15154/1504041).